Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. Stock
Equities
RMDA
EGS381B1C015
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.19 EGP | +6.83% | +10.61% | +32.73% |
Sales 2024 * | 2.92B 62.31M | Sales 2025 * | 3.53B 75.45M | Capitalization | 3.26B 69.71M |
---|---|---|---|---|---|
Net income 2024 * | 388M 8.29M | Net income 2025 * | 534M 11.4M | EV / Sales 2024 * | 1.48 x |
Net Debt 2024 * | 1.07B 22.78M | Net Debt 2025 * | 766M 16.36M | EV / Sales 2025 * | 1.14 x |
P/E ratio 2024 * |
7.37
x | P/E ratio 2025 * |
5.63
x | Employees | - |
Yield 2024 * |
4.84% | Yield 2025 * |
8.04% | Free-Float | 50.28% |
1 day | +6.83% | ||
1 week | +10.61% | ||
Current month | +6.31% | ||
1 month | -12.05% | ||
3 months | -15.77% | ||
6 months | +44.08% | ||
Current year | +32.73% |
Managers | Title | Age | Since |
---|---|---|---|
Amr Morsy
CEO | Chief Executive Officer | - | 10-12-31 |
Mahmoud Fayek
DFI | Director of Finance/CFO | - | 18-12-31 |
Rania Farouk
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Farida Khamis
BRD | Director/Board Member | - | 19-12-31 |
Director/Board Member | 65 | 18-12-31 | |
Director/Board Member | - | 10-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-19 | 2.19 | +6.83% | 7,924,592 |
24-05-16 | 2.05 | +3.54% | 7,047,411 |
24-05-15 | 1.98 | -0.50% | 3,123,296 |
24-05-14 | 1.99 | 0.00% | 1,961,645 |
24-05-13 | 1.99 | +0.51% | 3,385,068 |
End-of-day quote Egyptian Exchange, May 18, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+32.73% | 69.59M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+13.72% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- RMDA Stock